These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

694 related articles for article (PubMed ID: 30704681)

  • 21. 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.
    Weiner MW; Veitch DP; Aisen PS; Beckett LA; Cairns NJ; Cedarbaum J; Green RC; Harvey D; Jack CR; Jagust W; Luthman J; Morris JC; Petersen RC; Saykin AJ; Shaw L; Shen L; Schwarz A; Toga AW; Trojanowski JQ;
    Alzheimers Dement; 2015 Jun; 11(6):e1-120. PubMed ID: 26073027
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in Alzheimer's disease. A review for the family physician.
    Roth ME
    J Fam Pract; 1993 Dec; 37(6):593-607. PubMed ID: 8245812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alzheimer's disease: early diagnosis and treatment.
    Chu LW
    Hong Kong Med J; 2012 Jun; 18(3):228-37. PubMed ID: 22665688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting.
    Perani D; Cerami C; Caminiti SP; Santangelo R; Coppi E; Ferrari L; Pinto P; Passerini G; Falini A; Iannaccone S; Cappa SF; Comi G; Gianolli L; Magnani G
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):499-508. PubMed ID: 26341365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative.
    Gomar JJ; Bobes-Bascaran MT; Conejero-Goldberg C; Davies P; Goldberg TE;
    Arch Gen Psychiatry; 2011 Sep; 68(9):961-9. PubMed ID: 21893661
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative evaluation of disease progression in a longitudinal mild cognitive impairment cohort.
    Runtti H; Mattila J; van Gils M; Koikkalainen J; Soininen H; Lötjönen J;
    J Alzheimers Dis; 2014; 39(1):49-61. PubMed ID: 24121959
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer's Disease.
    Khan S; Barve KH; Kumar MS
    Curr Neuropharmacol; 2020; 18(11):1106-1125. PubMed ID: 32484110
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Awareness disorders in Alzheimer's disease and in mild cognitive impairment].
    Jacus JP; Dupont MP; Herades Y; Pelix C; Large H; Baud M
    Encephale; 2014 Apr; 40(2):180-7. PubMed ID: 24630532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarkers for preclinical Alzheimer's disease.
    Tan CC; Yu JT; Tan L
    J Alzheimers Dis; 2014; 42(4):1051-69. PubMed ID: 25024325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia.
    Trzepacz PT; Yu P; Sun J; Schuh K; Case M; Witte MM; Hochstetler H; Hake A;
    Neurobiol Aging; 2014 Jan; 35(1):143-51. PubMed ID: 23954175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early diagnosis beneficial in Alzheimer's disease.
    Allan CL; Behrman S; Ebmeier KP
    Practitioner; 2013 Jan; 257(1757):15-8, 2. PubMed ID: 23469723
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
    Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP
    Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical indications for analysis of Alzheimer's disease CSF biomarkers.
    Engelborghs S
    Rev Neurol (Paris); 2013 Oct; 169(10):709-14. PubMed ID: 24016466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alzheimer's disease dementia guidelines for diagnostic testing: a systematic review.
    Arevalo-Rodriguez I; Pedraza OL; Rodríguez A; Sánchez E; Gich I; Solà I; Bonfill X; Alonso-Coello P
    Am J Alzheimers Dis Other Demen; 2013 Mar; 28(2):111-9. PubMed ID: 23288575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The biomarker and therapeutic potential of miRNA in Alzheimer's disease.
    Bekris LM; Leverenz JB
    Neurodegener Dis Manag; 2015; 5(1):61-74. PubMed ID: 25711455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Biomarkers in Alzheimer's disease].
    García-Ribas G; López-Sendón Moreno JL; García-Caldentey J
    Rev Neurol; 2014 Apr; 58(7):308-17. PubMed ID: 24677154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) Project.
    van Maurik IS; Zwan MD; Tijms BM; Bouwman FH; Teunissen CE; Scheltens P; Wattjes MP; Barkhof F; Berkhof J; van der Flier WM;
    JAMA Neurol; 2017 Dec; 74(12):1481-1491. PubMed ID: 29049480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advances in imaging-genetic relationships for Alzheimer's disease: clinical implications.
    Bagnoli S; Piaceri I; Sorbi S; Nacmias B
    Neurodegener Dis Manag; 2014; 4(1):73-81. PubMed ID: 24640981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alzheimer's disease: Unique markers for diagnosis & new treatment modalities.
    Aggarwal NT; Shah RC; Bennett DA
    Indian J Med Res; 2015 Oct; 142(4):369-82. PubMed ID: 26609028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Can multi-modal neuroimaging evidence from hippocampus provide biomarkers for the progression of amnestic mild cognitive impairment?
    Chen J; Zhang Z; Li S
    Neurosci Bull; 2015 Feb; 31(1):128-40. PubMed ID: 25595368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.